Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2014-01, Vol.25 (1), p.298-299
Hauptverfasser:	Maie, K., Okoshi, Y., Takaiwa, N., Kurita, N., Hasegawa, Y., Homma, M., Ishii, K., Kohda, Y., Chiba, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Murine-Derived - administration & dosage Antiemetics - therapeutic use Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Aprepitant Biological and medical sciences Cyclophosphamide - administration & dosage Doxorubicin - administration & dosage Drug Interactions Humans Lymphoma, Non-Hodgkin - drug therapy Medical sciences Morpholines - pharmacology Morpholines - therapeutic use Nausea - chemically induced Nausea - drug therapy Pharmacology. Drug treatments Prednisolone - administration & dosage Prednisolone - pharmacokinetics Rituximab Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!